Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 23-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 44)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-Nov-09 New Constructs, LLC N/A AMED: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
20-Nov-09 Stock Traders Daily Thomas H. Kee Jr. S&P Valuation Analysis 13 $50 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: AMEDISYS -- AMED 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: AFAM , AMED , AMSG , KAD , CNU , DCAI , INMD , NOVA -- MEDICAL SERVICES 3 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of AMEDISYS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
15-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (Global) 148 $169 View Abstract
15-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 103 $169 View Abstract
Next 20

Brokerage Reports (Showing 1 to 2 of 2)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
27-Oct-09 Thomson StreetEvents N/A AMED - Event Transcript of Amedisys, Inc. conference call, Oct. 27, 2009 / 10:00am ET 22 $75 View Abstract
27-Oct-09 Thomson StreetEvents N/A AMED - Event Brief of Amedisys, Inc. conference call, Oct. 27, 2009 / 10:00am ET 23 $75 View Abstract

Independent Reports (Showing 1 to 10 of 42)

Release
Date Contributor Author Title Pages Price More Info
20-Nov-09 New Constructs, LLC N/A AMED: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
20-Nov-09 Stock Traders Daily Thomas H. Kee Jr. S&P Valuation Analysis 13 $50 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: AMEDISYS -- AMED 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: AFAM , AMED , AMSG , KAD , CNU , DCAI , INMD , NOVA -- MEDICAL SERVICES 3 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of AMEDISYS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
15-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (Global) 148 $169 View Abstract
15-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 103 $169 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.